Gilad Moiseyev - 25 May 2026 Form 4 Insider Report for Brainsway Ltd. (BWAY)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
22 Jun 2026, 16:04:26 UTC
Prior SEC filing
18 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Gilad Moiseyev

Key filing fact

Gilad Moiseyev filed Form 4 for Brainsway Ltd. (BWAY) on 22 Jun 2026.

Key facts

  • This page summarizes Gilad Moiseyev's Form 4 filing for Brainsway Ltd. (BWAY).
  • 4 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 22 Jun 2026, 16:04.

Change

  • Previous filing in this sequence was filed on 18 Mar 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002111634 Primary reporting owner

Moiseyev Gilad

Relationship
Chief Technology Officer
Address
16 HARTUM STREET, RAD TOWER, 14TH FLOOR, HAR HAHOTZVIM, JERUSALEM, ISRAEL
Signature
/s/ Gilad Moiseyev
Signature date
22 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BWAY transaction

Ordinary Shares

Options Exercise

Transaction value
Shares
+7,500
Change %
+14%
Price
Shares after
60,000
Date
25 May 2026
Ownership
Direct
Footnotes
F1, F2, F3
BWAY transaction

Ordinary Shares

Tax liability

Transaction value
Shares
-1,902
Change %
-3.2%
Price
Shares after
58,098
Date
25 May 2026
Ownership
Direct
Footnotes
F1, F3, F4
BWAY transaction

Ordinary Shares

Sale

Transaction value
Shares
-5,000
Change %
-8.6%
Price
Shares after
53,098
Date
15 Jun 2026
Ownership
Direct
Footnotes
F1, F3, F5

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BWAY transaction Derivative

Stock Options (right to buy)

Options Exercise

Transaction value
Shares
-7,500
Change %
-25%
Price
$0.000000*
Shares after
22,500
Date
25 May 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
7,500
Exercise price
Footnotes
F1, F2, F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Footnote F2

The exercise price is NIS 11.17 per share.

Footnote F3

This figure includes ordinary shares and unvested restricted stock units ("RSUs"), with each RSU representing a contingent right to receive one ordinary share, as follows: (a) RSUs to receive 6,563 ordinary shares vesting in equal quarterly installments until March 5, 2028, (b) RSUs to receive 10,000 ordinary shares with 2,500 vesting on November 10, 2026 and the remainder vesting in equal quarterly installments until November 10, 2029 and (c) RSUs to receive 27,500 ordinary shares with 6,875 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030.

Footnote F4

These shares were retained by the Company at a price of NIS 44.04 per share in payment of the exercise price of the employee stock options exercised by the Reporting Person.

Footnote F5

The sale price was NIS 42.0397 per share.

Footnote F6

Stock options were granted on March 5, 2024, with the remaining options to purchase 13,125 ordinary shares vesting in equal quarterly installments until March 5, 2028.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .